Information on the deposit of biological materials in depositories is required for (a) the United States Patent and Trademark Office (USPTO) determination of compliance with 35 U.S.C. 2(b)(2) and 112, and 37 CFR 1.801-1809, where inventions sought to be patented rely on biological material subject to the deposit requirements, including notification to the interested public on where to obtain samples of deposits; and (b) in compliance with 37 CFR 1.803 to demonstrate that the depositories are qualified to store and test the biological material submitted to them under patent application.
For this renewal, the USPTO estimates that the items in this information collection will naturally fluctuate based on respondent need. Overall USPTO is estimating that these adjustments result in more responses (+2,350) and associated time burden (+2,350). USPTO is estimating that total annual (non-hour) costs will increase (+$6,436,572) due to the corresponding increase in responses.
$39,559
No
Yes
No
No
No
No
No
Raul Tamayo 571 272-7728 raul.tamayo@uspto.gov
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/28/2023
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.